CellCarta Executive and Leadership Team

Elliott Miller, the Chief Financial Officer at CellCarta, manages the fiscal strategy and capital allocation for the global Contract Research Organization. Miller oversees financial planning, budgeting, and resource distribution to support the expansion of biomarker testing services across diverse international markets. By analyzing revenue streams from biopharmaceutical partnerships, the Chief Financial Officer ensures the long-term sustainability of the company's research infrastructure. This leadership role involves coordinating with the Board to evaluate investment opportunities in new diagnostic technologies and laboratory equipment. Elliott Miller drives financial performance through rigorous cost management and strategic forecasting, enabling the organization to scale operations effectively. The Chief Financial Officer maintains transparency in reporting and regulatory compliance, fostering trust with stakeholders. Through disciplined fiscal oversight, Miller supports the company's mission to provide high-value scientific testing solutions while maintaining a robust balance sheet for future growth.

Louis Norton, the Chief Information Officer at CellCarta, directs the digital infrastructure supporting global biomarker research platforms. Norton architects secure data management systems to ensure compliance with international biopharmaceutical standards while optimizing laboratory information management workflows. By integrating advanced analytics into the research lifecycle, the Chief Information Officer drives operational efficiency across all international facilities. This leadership role involves overseeing cybersecurity protocols to protect sensitive clinical trial data and proprietary research findings. Louis Norton maintains alignment between technological capabilities and the evolving needs of precision medicine clients. Through the implementation of scalable cloud solutions, the Chief Information Officer facilitates seamless collaboration between global research teams. Ultimately, Norton secures the digital foundation necessary for high-throughput scientific testing, ensuring that data integrity remains a cornerstone of the company's service offerings to the biopharmaceutical industry.

Marcus Silva, the Chief Marketing Officer Head of Strategic Partnerships at CellCarta, directs the global brand positioning and alliance development for the organization. Silva architects outreach programs to connect the company's biomarker platforms with biopharmaceutical innovators seeking precision medicine solutions. By identifying key market opportunities, the Chief Marketing Officer Head of Strategic Partnerships expands the reach of laboratory services into new therapeutic areas. This leadership role involves cultivating long-term relationships with industry leaders to foster collaborative research initiatives. Marcus Silva drives market awareness through targeted campaigns that highlight the company's unique scientific capabilities and technical expertise. The Chief Marketing Officer Head of Strategic Partnerships ensures that the value proposition remains clear to potential partners, facilitating growth in both North American and international markets. Through strategic networking and market analysis, Silva secures a competitive advantage for the company within the global research landscape.

Ehab ElGabry, the Chief Medical Officer at CellCarta, provides clinical leadership and scientific guidance for all biomarker testing services. ElGabry oversees the medical integrity of research protocols, ensuring that laboratory outputs meet the rigorous requirements of the biopharmaceutical industry. By directing the interpretation of complex clinical data, the Chief Medical Officer supports the development of precision medicine therapies for global clients. This leadership role involves collaborating with internal research teams to validate new diagnostic platforms and maintain high standards of scientific excellence. Ehab ElGabry drives the integration of medical expertise into the company's service offerings, bridging the gap between laboratory findings and clinical application. The Chief Medical Officer ensures that all testing procedures align with international regulatory guidelines, protecting the quality of research outcomes. Through continuous scientific oversight, ElGabry maintains the company's reputation as a trusted partner in the advancement of modern medicine.